Vanda Pharmaceuticals
VNDA
#7119
Rank
A$0.73 B
Marketcap
A$12.36
Share price
2.21%
Change (1 day)
65.63%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$57.19 Million a decrease over its 2023 earnings that were of -A$19.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion228.98%
2024 -A$57.19 Million191.43%
2023 -A$19.63 Million-320.45%
2022 A$8.9 M-84.99%
2021 A$59.29 M54.8%
2020 A$38.3 M19.42%
2019 A$32.07 M4.93%
2018 A$30.57 M-228.6%
2017 -A$23.78 Million-8.98%
2016 -A$26.12 Million-53.79%
2015 -A$56.52 Million-30.18%
2014 -A$80.94 Million173.08%
2013 -A$29.64 Million-25.33%
2012 -A$39.7 Million163.61%
2011 -A$15.06 Million-221.15%
2010 A$12.42 M-124.53%
2009 -A$50.68 Million-29.44%
2008 -A$71.82 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$92.41 Million170.55%
2005 -A$34.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.55 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.99 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.66 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.64 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.47 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.29 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$3.95 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA